Table 2 Comparison of resource use in monitoring of biological therapy in the nurse-led rheumatology clinic (NLC) and the rheumatologist-led clinic (RLC) over 12 months

Any additional contacts

0

13 (28)

12 (24)

25 (26)

≥1

34 (72)

38 (76)

72 (74)

Additional phone, nurse

0

26 (55)

27 (54)

53 (55)

≥1 Range 1–7

21 (45)

23 (46)

44 (45)

Additional phone, rheumatologist

0

41 (87)

41 (82)

82 (85)

≥1 Range 1–4

6 (13)

9 (18)

15 (15)

Additional rheumatologist visits

0

42 (89)

39 (78)

82 (85)

≥1 Range 1–2

5 (11)

11 (22)

15 (15)

Addition cortisone inj. rheumatologist

0

36 (77)

42 (84)

78 (80)

≥1 Range 1–3

11 (23)

8 (16)

19 (20)

Additional blood tests

0

36 (77)

27 (54)

63 (65)

≥1 Range 1–12

11 (23)

23 (46)

34 (35)

Team rehabilitation inpatients (days)

0

47 (100)

46 (92)

93 (96)

≥1 Range 15–24

0 (0)

4 (8)

4 (4)

Team Rehabilitation outpatients (days)

0

46 (98)

50 (100)

96 (99)

≥1 Range 15–15

1 (2)

0 (0)

1 (1)

Physiotherapy

0

45 (96)

47 (94)

92 (95)

≥1 Range 3–21

2 (4)

3 (6)

5 (5)

Occupational therapist

0

47 (100)

49 (98)

96 (99)

≥1 Range 3–3

0 (0)

1 (2)

1 (1)

Psychosocial treatment

0

47 (100)

49 (98)

96 (99)

≥1 Range 1–1

0 (0)

1 (2)

1 (1)

Specialist consulting

0

35 (74)

39 (78)

74 (76)

≥1 Range 1–2

12 (26)

11 (22)

33 (34)

Radiography

0

32 (68)

34 (68)

66 (68)

≥1 Range 1–5

15 (32)

16 (32)

31 (32)